Perioperative blood transfusion and outcome after resection for colorectal carcinoma

British Journal of Surgery

Volumn 80, Issue 4, 1993, Pages 427-432

  Chung, M ^a   Steinmetz, O K ^a   Gordon, P H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; COLORECTAL CARCINOMA; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW;

BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; HUMAN; IMMUNE TOLERANCE; INTRAOPERATIVE PERIOD; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; RISK FACTORS; TREATMENT OUTCOME;

EID: 0027450573     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800800407     Document Type: Review

References (57)

1. Effect of blood transfusion on colonic malignancy recurrence rate
2. Secondary prevention of vascular disease by prolonged antiplatelet treatment
3. Beta blockade during and after myocardial infarction: an overview of randomized trials
4. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma
5. Perioperative blood transfusion in patients with colon carcinoma
6. Relation between recurrence of cancer of the colon and blood transfusion
7. Peri‐operative blood transfusions in colorectal cancer
8. Adverse relationship between blood transfusions and survival after colectomy for colon cancer
9. Perioperative blood transfusion and cancer prognosis
10. Relationship between cancer of the colon and blood transfusion
11. Perioperative allogenic blood transfusions: survival in patients with resected carcinomas of the colon and rectum
12. Effect of perioperative blood transfusion on recurrence of colorectal cancer
13. Blood transfusion and the recurrence of cancer of the colon and rectum
14. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence
15. Blood transfusion and colorectal cancer
16. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer
17. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma
18. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival
19. Perioperative blood transfusion and recurrence and death after resection for cancer of the colon and rectum
20. Blood transfusions and survival after colectomy for colorectal cancer
21. Blood transfusion in colorectal cancer
22. Association between transfusion with plasma and the recurrence of colorectal carcinoma
23. Perioperative blood transfusions and colorectal cancer outcome
24. Adverse effect of blood transfusions on patient survival after resection of rectal cancer
25. The blood transfusion effect and colorectal cancer recurrence
26. Blood transfusions and survival after resection of cancers of the breast, colon, and lung: the need for prospective randomized trials
27. Improvement of kidney‐graft survival with increased numbers of transfusions
28. Effect of perioperative blood transfusion on recurrence of Crohn's disease
29. Perioperative blood transfusion has prognostic significance for breast cancer
30. Blood transfusion and survival after lung cancer resection
31. Perioperative blood transfusion adversely affects prognosis in patients with stage I non‐small cell lung cancer
32. Relation between recurrence of cancer and blood transfusion
33. A possible association between survival time and transfusion in patients with cervical cancer
34. Blood transfusion and outcome in stage III head and neck carcinoma
35. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high grade soft‐tissue sarcomas of the extremities
36. Local recurrence of rectal carcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision
37. Recurrence and survival after total mesorectal excision for rectal cancer
38. Mechanisms of transfusion‐induced immunosuppression
39. Effect of transfusion on immune function in a traumatized animal model
40. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis
41. Diminished helper‐suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions
42. Chronic transfusion alters T lymphocyte subpopulations in children with sickle cell disease
43. Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease
44. Immunologic abnormalities in patients receiving multiple blood transfusions
45. Acceleration of B16 melanoma growth in mice after blood transfusion
46. Transfusion‐induced immunosuppression results in diminished host survival in a murine neuroblastoma model
47. Effect of blood transfusion on IL‐2 production
48. Effect of blood transfusion on immune function. III. Alterations in macrophage arachidonic acid metabolism
49. Effect of blood transfusions on macrophage–lymphocyte interaction in an animal model
50. Blood transfusion and allograft survival: iron related immunosuppression
51. Suppressive effect of ferritin o. in vitro lymphocyte function
52. Impaired T‐cell mitogen response in some patients with thalassemia intermedia
53. Improved renal allograft survival after blood transfusion: a non‐specific, erythrocyte‐mediated immunoregulatory process
54. Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis
55. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations
56. Relationship of transfusion and infectious complications after gastric carcinoma operations
57. Unnecessary blood transfusions in elective colorectal cancer surgery